Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19

in Anti-Infective Agents

• Peter Buchwald

COVID-19 Therapies: Protease Inhibitions and Novel Degrader Strategies

in Anti-Infective Agents

• Michèle Reboud-Ravaux
• Chahrazade El Amri

The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19

in Anti-Infective Agents

• Ana C. Puhl
• Thomas R. Lane
• Fabio Urbina
• Sean Ekins

Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It

in Anti-Infective Agents

• Michael Zhipeng Yan
• Ming Yang
• Ching-Lung Lai

A Mini-Review of the Anticancer Properties of Cryptotanshinone: A Quinoid Diterpene Extracted From the Root of Salvia miotiorrhiza Bunge

in Anti-Cancer Drugs

• Mahdyieh Naziri
• Arezoo Ghafari
• Hoda Mehrabi
• Elham Ramezannezhad
• Farzaneh Nazari
• Arina Ansari
• Farhad Nikzad
• Niloofar Deravi

Deep Machine Learning for Computer-Aided Drug Design

in In silico Methods and Artificial Intelligence for Drug Discovery

• Jürgen Bajorath

Is Covid-19 Severity Associated With ACE2 Degradation?

in In silico Methods and Artificial Intelligence for Drug Discovery

• Ugo Bastolla
• Patrick Chambers
• David Abia
• Maria-Laura Garcia-Bermejo
• Manuel Fresno

Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism

in Neurological Drugs

• Christopher R. Apostol
• Kelsey Bernard
• Parthasaradhireddy Tanguturi
• Gabriella Molnar
• Mitchell J. Bartlett
• Lajos Szabò
• Chenxi Liu
• J. Bryce Ortiz
• Maha Saber
• Katherine R. Giordano

Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient

in Neurological Drugs

• Nuno Jorge Lamas
• Laurent Roybon

Deep Learning Prediction of Adverse Drug Reactions in Drug Discovery Using Open TG–GATEs and FAERS Databases

in In silico Methods and Artificial Intelligence for Drug Discovery

• Attayeb Mohsen
• Lokesh P. Tripathi
• Kenji Mizuguchi

Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges

• Bruno O. Villoutreix

Grand Challenges of Computer-Aided Drug Design: The Road Ahead

in In silico Methods and Artificial Intelligence for Drug Discovery

• José L. Medina-Franco